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Abstract
Background: Individuals with obstructive sleep apnoea (OSA) experience a higher burden of
atrial fibrillation (AF) than the general population, and many cases of AF remain undetected.
We tested the feasibility of an artificial intelligence (AI) approach to opportunistic detection
of AF from single-lead electrocardiograms (ECGs) which are routinely recorded during inlaboratory polysomnographic sleep studies.
Methods: Using transfer learning, an existing ECG AI model was applied to 1839 single-lead
ECG traces recorded during in-laboratory sleep studies without any training of the algorithm.
Manual review of all traces was performed by two trained clinicians who were blinded to
each other’s review. Discrepancies between the two investigators were resolved by two
cardiologists who were also unaware of each other’s scoring. The diagnostic accuracy of the
AI algorithm was calculated against the results of the manual ECG review which were
considered gold standard.
Results: Manual review identified AF in 144 of the 1839 single-lead ECGs (7.8%). The AI
detected all cases of manually confirmed AF (sensitivity = 100%, 95% CI: 97.5 - 100.0). The
AI model misclassified many ECGs with artefacts as AF, resulting in a specificity of 76.0
(95% CI: 73.9 - 78.0), and an overall diagnostic accuracy of 77.9% (95% CI: 75.9% 97.8%).
Conclusion: Transfer learning AI, without additional training, can be successfully applied to
disparate ECG signals, with excellent negative predictive values, and can exclude AF among
patients undergoing evaluation for suspected OSA. Further signal-specific training is likely to
improve the AI’s specificity and decrease the need for manual verification.
Key words: Atrial Fibrillation, Machine learning, Artificial Intelligence, Transfer Learning,
Obstructive sleep apnoea.

INTRODUCTION
AF is the most common clinically significant cardiac arrhythmia encountered in clinical
practice [1]. It is associated with a 5-fold increased risk of stroke, a 3-fold increased risk of
heart failure, reduced quality of life and increased mortality [2-5]. Paroxysmal AF (PAF) is
often asymptomatic and therefore not diagnosed until the occurrence of thromboembolic
complications, such as stroke [6]. AF-related strokes are nearly twice as likely to be fatal as
non-AF strokes, and are associated with more severe functional deficits, higher mortality and
higher risk of recurrence [7]. Recent studies have shown that up to 20% of patients with AF
remain undiagnosed [8, 9]. Of more concern is that half of older individuals with
undiagnosed AF are in the high-risk category for stroke [10]. While anticoagulation has been
shown to decrease embolic risks in the setting of atrial fibrillation, more than 20% of patients
who experience an AF-related stroke have not received guideline-directed preventative
anticoagulation therapy due to delayed diagnosis [6]. As such, there has been a growing
interest in opportunistic as well as structured screening strategies to improve early detection
of AF in high-risk groups to reduce the risk of AF-related complications.
Obstructive sleep apnoea (OSA) has been recognised as an important risk factor for
development of AF. Patients with OSA are four times more likely to develop AF compared to
the general population and the risk of AF is influenced by the severity of OSA [11]. The
burden of both AF and OSA is increasing with an ageing population and increased rates of
cardiovascular comorbidities such as obesity, hypertension, metabolic disease, and heart
failure [12-14]. The coexistence of AF and OSA represents a significant public health burden
due to shared risk factors and associated complications. As with AF, previous studies have
shown that OSA is also an independent risk factor for stroke [15-17]. However, it remains
unclear to what extent this increased risk is due to undiagnosed AF in patients with OSA.
Currently, there are no established strategies for the detection of AF in patients with
confirmed or suspected OSA, beyond what is available to the general population, which also
remains under active investigation [18, 19]. Previous studies have shown that PAF is
seventeen times more likely to occur during respiratory disturbances than during normal
breathing [20], suggesting that the rate of detection of PAF in patients with OSA could be
higher during sleep compared to daytime. AF can be “opportunistically” detected in patients
undergoing sleep studies using traditional sleep apnoea diagnostic methods with abilities to
acquire ECG data. However, the ability to detect AF with this strategy is currently limited by

the lack of automated arrhythmia detection technology, as manual interpretation requires
extensive resources and appropriate clinical training.
Artificial Intelligence (AI) is a novel method of ECG analysis that uses machine learning
(ML) to detect patterns within electrical waveforms and may potentially be ideally suited for
automated application to the ECG component of overnight sleep studies. AI has the potential
to improve the early detection of PAF by providing efficiency gains (through automation)
and improved accuracy of detection [21]. Recent data have demonstrated great promise in AI
being able to classify AF from other cardiac arrhythmias with an accuracy that is superior to
that of physicians [22]. Unlike most current AF-detection technologies, which have limited
abilities to analyse large datasets, AI-based technologies are robust and are well suited to
large amounts of ECG data, including those obtained from Holter monitors, implantable
arrhythmia devices. Our study aimed to test the feasibility of utilising transfer learning of a
previously trained AI technology, for opportunistic detection of atrial fibrillation from
polysomnographic ECG traces.
MATERIALS AND METHODS
Population and data collection
One hundred and ninety patients who underwent an in-laboratory polysomnographic
evaluation for suspected obstructive sleep apnoea between 2012 and 2017 were identified
from a sleep clinic’s database. This included 75 consecutive patients who had a final
diagnosis of moderate to severe OSA (Apnoea-hypopnoea index, AHI > 15), 50 consecutive
patients with mild or no OSA (AHI <15), and 65 patients with a previously documented
history of atrial fibrillation, irrespective of the final OSA diagnosis. Selection of these
patients was based on OSA and AF diagnosis only and did not consider the quality of the
ECG traces. There were no specific exclusion criteria. For each patient, 7 to 11 single-lead
ECG traces were retrieved from the database. This resulted in 1839 single-lead ECG traces
that were analysed in the study. Ethical approval was granted through the University of
Notre Dame Australia Human Research Ethics Committee (Ref # 019028F) and the study
complied with the ethical guidelines of the 1975 Declaration of Helsinki [23].
Training and validation of the AI
The project was conducted within a framework of concurrent training and validation of a
flexible ECG waveform analysis AI, which is currently under development. The goal of this

strategy is to develop a model that is capable of being deployed to many different types of
ECG signals acquired using differing methodologies, including short term single lead ECG
traces (“event” recorders), 12-lead surface ECGs, 24-hour continuous ECG recordings
(“holter” monitors), subcutaneous implanted event recorders (“loop” recorders), intracardiac
ECGs obtained during electrophysiology studies, and single-lead ECGs from
polysomnograms. Prior to the commencement of the current study, the AI model had
undergone two levels of training. The first was with >18,000 individual 12-lead ECGs using
a single training technique (multilayer convolutional neural network producing a single
connected layer). The results of the base AI model 12 lead ECG analysis showed a sensitivity
of 95%, specificity of 94%, and a PPV of 92% for the detection of atrial fibrillation
(unpublished data). The second level involved transfer learning (a method by which an
existing machine learning AI model is applied to a disparate data set) [24], where the AI
model was further trained on >700 individual ECGs from implanted loop recorders (these
devices generate a single channel ECG signal). This newly trained model was then applied
directly (without further training) to the single-lead ECGs recorded during in-laboratory
polysomnographic sleep studies for the detection of AF.
Analysis of the ECG traces
All 1839 ECG traces, irrespective of their quality, were individually uploaded as EDF
(European Data Format) files to a web Holter system. This system allows the investigator to
specifically upload the cardiac component of a full sleep study while eliminating the noise
generated by other sleep study parameters. Each uploaded ECG recording was analysed by
the rhythm AI model and beat-detection algorithm, which subsequently generated the
associated rhythm and beat events.
Following automated AI analysis, each individual ECG trace was manually reviewed by two
independent clinicians using the process outlined in figure 1. The first reviewer analysed each
individual ECG trace and classified the ECG as either “AF” or “no AF”. A second
investigator reviewed the same ECG traces who reported the same classifications. Both
reviewers were blinded to the diagnosis scored by the sleep scientists and each other but had
access to the diagnosis scored by the AI model. The first 500 ECG traces were used to
calculate the inter-rater agreement between the two investigators. Discrepancies were
adjudicated by a panel comprising of two cardiologists who reviewed the ECG traces
independently, blinded to each other’s review. The protocol allowed for discrepancies

between the two cardiologists to be resolved in a meeting between the adjudication panel that
included a third cardiologist, external to this process. The final diagnosis scored by the
manual review process was used as the gold standard against which the performance of the
AI model was compared.
Statistical analysis
Cohen’s Kappa statistic was used to determine the interobserver correlation coefficients. The
diagnostic accuracy of the AI system for the detection of AF was evaluated in all 1839 traces.
The analysis of the diagnostic accuracy of the AI algorithm was performed using the method
previously described by Šimundić [25] where the manual ECG review by the investigators
was considered as gold standard (i.e. true positive; true negative). Using this method, we
determined the sensitivity and specificity, and the positive and negative predictive values of
the AI algorithm for the detection of AF. The sensitivity was calculated as the percentage of
true positives (true positive/(true positive + false negative)) and the specificity as the
percentage of true negatives (true negative/(true negative + false positive)). The positive
predictive values (PPV) and negative predictive values (NPV) were calculated as the
percentages of patients with positive test (PPV = true positive/(true positive + false positive))
and negative results (NPV = true negative/(true negative + false negative)). Where
appropriate, MedCalc statistical software for Windows version 18 (MedCalc Software,
Belgium) was used for statistical analysis.
RESULTS
ECG analysis by manual review
A total of 190 patients undergoing evaluation for suspected OSA were included in this
retrospective study. Each patient contributed 7 to 11 traces, resulting in 1839 single-lead
ECG traces. The mean duration of recording of the ECGs was 57.43 ± 9.61 minutes (range: 4
minutes to 60 minutes).
Manual review of the ECGs identified AF in 144 ECG traces (7.8%). There was an excellent
agreement between the first and second reviewers (k = 0.97). Disagreements occurred on 10
traces, which were subsequently evaluated by two independent cardiologists, who provided
the final diagnosis (Figure 1). There were no disagreements between the two cardiologists
that required involvement of a third cardiologist.
ECG analysis by the artificial intelligence

The AI model performed a beat-by-beat analysis of the uploaded ECGs and provided a
rhythm diagnosis within seconds. For each segment of the ECG that was analysed, the AI
model determined the duration of the detected arrhythmia (or sinus rhythm) and recorded it
below the ECG trace (Figure 2). For each ECG trace, we recorded the duration of the longest
segment that was detected as AF by the AI model. For example, if a 60-minute ECG trace
had 6 segments of AF (30 seconds; 2 minutes; 5 minutes; 10 minutes; 20 minutes; 25
minutes), the duration of the longest segment with AF (i.e., 25 minutes) was recorded.
Of the 1839 single-lead ECGs that were uploaded to the online platform, the AI algorithm
detected AF in 551 traces (30%). All ECG traces that were classified as AF by the manual
review were accurately detected by the AI algorithm, resulting in a sensitivity of 100% (95%
confidence interval [CI]: 97.5 - 100.0). The AI algorithm misclassified 407 ECG traces as AF
(table 1), resulting in a specificity of 76.0 (95% CI: 73.9 - 78.0). The misclassification was
predominantly due to the presence of artefact, predominantly due to muscle motion (figure
3). Furthermore, many short segments of normal sinus rhythm were also misidentified as AF
by the AI algorithm (An example is shown in figure 4). Indeed, of the 407 ECGs that were
incorrectly classified as AF by the AI, the majority (73%) were short segments of artefacts or
sinus rhythm of less than 30 seconds (table 2). The overall positive predictive value of
detected AF by the AI algorithm was 26.1% (95% CI: 24.5 % to 27.8 %).
DISCUSSION
To our knowledge, this is the first study to uniquely examine the feasibility of using transfer
learning techniques for application of a novel machine learning AI algorithm for automated
detection of AF from ECG traces, recorded during in-laboratory polysomnographic studies.
Using a robust method of manual adjudication for AF, the AI model achieved 100%
sensitivity but with frequent AF classification of artefact and short-duration sinus rhythm.
Since the model was applied directly without specific AI training on a PSG-derived ECG
signal, the results confirm two important findings: First, without further training, an ECG AI
system can be applied to disparate ECG signals, and Second: An AI-based approach to AF
detection during PSG for sleep apnoea is technically feasible. Due to its high NPV, the
current AI model would be most suitable as a means for excluding a diagnosis of AF, and AIdetected positive would require manual review. We expect that false positive rates would
improve with transfer learning and additional PSG ECG-specific training.

The ability to accurately detect AF from PSG-derived ECG signals using a robust AI
algorithm would have major clinical implications. From a logistical point of view, it could be
used to highlight possible AF for review, which would improve the workflow in the sleep
clinic and reduce the costs associated with manual review of large ECG data. Furthermore,
the anticipation, as suggested by recent data, is that AI may be able to classify AF from other
arrhythmias with an accuracy that is similar or greater to that of physicians [22]. This would
be a great advantage in the sleep clinic where PSG-derived ECGs are interpreted by sleep
physiologists whose primary focus is on respiratory scoring. Evidence suggests that the
accuracy of AF detection from single-lead ECGs is very low among non-clinical personnel
[26]. As such, it would be expected that AI-based ECG review would optimise the detection

of AF in the sleep clinic though this would require further prospective studies for
confirmation. Such an advancement could have major implications on the overall care of the
patient, such as leading to the timely initiation of anticoagulation for stroke prevention.
However, the application of AI in clinical medicine remains challenging. First, the training
phases of AI algorithms are limited by the lack of standardised training protocols, and
availability of large datasets [27]. In addition, the validation of new AI models is often
performed against diagnostic rather than clinical outcomes, and the performance
generalisability is limited by overfitting. Because AI models are trained for specific tasks,
many such algorithms perform well on datasets that are most closely related to the datasets
used in the training phase [28]. Consequently, poor performance is often observed when such
algorithms are applied to datasets that are less representative of the training datasets [28]. It is
therefore unsurprising that our AI algorithm, which had not been trained on sleep ECGs, had
a low specificity for AF detection in this group. Therefore, before any AI model can be
applied to clinical practice, it must overcome these limitations [27]. In addition, robust
evidence of clinical utility needs to be demonstrated in prospective clinical trials prior to AI’s
application in routine clinical practice.We also acknowledge several limitations specific to
the current study. First, this is a single-centre proof-of-concept study, and whilst our data are
promising, larger studies are required to confirm the results. Secondly, an inherent limitation
of using single-lead ECG recordings is that the accuracy of AF identification from these
recordings is generally only moderate when compared to 12-lead ECGs [29]. This is often
due to the confusion created by artefacts, which may be even greater in PSG as ECG
recording in this setting is not the primary objective. Our study included all eligible ECGs
irrespective of their quality and as such, it is highly likely that artefactual ECGs were major

drivers of the AI’s low specificity. This is an important limitation because the AI model used
in our study had only been trained to perform a binary classification (AF vs no AF –
primarily sinus rhythm). As such, a high prevalence of ECGs with artefacts, other non-AF
atrial arrhythmias, sinus pauses, and supraventricular and ventricular ectopics, which are
frequently observed in patients with OSA [30-32], potentially contributed to the reduced
specificity resulting from a misclassification of these non-AF arrhythmias and artefacts as AF
by the AI model. Indeed, artefacts and traces of short-duration sinus rhythm accounted for
most AF misclassifications. This could be addressed by performing a PSG ECG signal
specific training of the AI model and by introducing new classes for the classifier to include
categories for noise/unreadable, as well as specific non-AF cardiac arrhythmias. In addition,
the AI model had only been previously trained on 12-lead ECGs and implanted loop
recorders, both of which have relatively low artefact compared with the ECGs in the present
study.
Finally, the current study utilised the default system probability threshold of 0.5 for AI’s
binary classification of AF vs no AF. This likely led to a bias towards a high sensitivity and
NPV at the expense of specificity and PPV. Future work could analyse the AI’s performance
for classification of AF across a range of probability thresholds, which may identify the
optimal probability threshold setting for this population. This could form basis for future
signal specific AI training on PSG-derived ECGs.
In spite of these limitations, the performance of the ECG AI algorithm that has never been
trained on this type of data is encouraging, suggesting that AI-based approach to AF
identification in a sleep clinic is feasible. This approach is likely to be more robust than
existing automated algorithms, which often perform well in training and validation phases but
poorly in real-life scenarios. This was previously demonstrated in the REHEARSE-AF trial
(Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen
for Atrial Fibrillation) where only 5% of AF detected by the AliveCor automated algorithm
were true AF, despite the previously reported specificity above 90% in validation cohorts [9,
33]. The current automated AF-detection algorithms are also only suitable for short ECG
strips and cannot be applied to PSG-derived ECG sets [34]. Therefore, AI algorithms offer a
better chance of achieving the automation of ECG analysis and arrhythmia detection in the
sleep clinic. A further advantage of the AI technology is the iterative ability of the deep
learning (utilised by our AI model) to continue learning and thereby improving its processing
speed and diagnostic accuracy over time, with and without explicit guidance [35-37]. It is

reasonable to believe that dedicated signal specific training of the AI using polysomnographic
ECG datasets would result in significant improvement of the AI’s ability to differentiate true
AF from sinus rhythm, artefacts, and other cardiac arrhythmias. The clinical utility of the AI
algorithm would require further prospective validation.
CONCLUSION
An ECG AI system, trained on completely different types of ECG data and applied to single
lead PSG ECG data for the first time, achieved surprisingly good results in detecting AF with
excellent negative predictive values. If confirmed in larger studies, this type of system could
be used to exclude AF among patients undergoing evaluation for suspected obstructive sleep
apnoea. The results suggest it is technically feasible to directly apply an ECG AI algorithm
trained using transfer learning to PSG studies. Signal-specific training is required to improve
the system’s performance for potential clinical utility.
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Figure 1. Flowchart demonstrating the process utilised for manual and automated classification
of electrocardiograms.

Figure 2. Example of a single-lead ECG analysed by the artificial intelligence algorithm.
Following an upload of an ECG trace, the AI performs a beat-by-beat analysis of the trace and
generates an accurate diagnosis of Atrial fibrillation as demonstrated here. The AI algorithm
also determines the duration of each arrhythmia that is detected. The online platform allows
for manual review and/or overread (in case of training) by clicking on the forward and
backward arrows as shown in the figure.

Figure 3. Artificial intelligence’s Analysis of two ECG traces with artefacts. In the first trace,
the AI accurately identifies artefacts on ECG (labelled “A”). In the second ECG trace, the AI
algorithm misclassifies artefacts as AF.

Figure 4. Example of a short segment of an ECG in sinus rhythm that was incorrectly identified
as AF by the AI algorithm.

